Institut Curie - Hôpital de Paris

Paris 75248

1 studies enrolling now · 3 studies all time

What they study most

Squamous NSCLC, TGCT, Uveal Melanoma

Studies at this site

• Adjuvant Tebentafusp in High Risk Ocular Melanoma — Recruiting now
• Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) — Running, not enrolling
• Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC) — Withdrawn before enrolling